NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Healshape

Healshape

Private
LyonHealthcare & Life Scienceshttps://healshape.com/

Last Round

Seed

Jun 28, 2022

Total Funding Raised

$6.3M

Company Overview

Healshape is a regenerative medicine company that develops 3D-bioprinted, personalized, and resorbable bioprostheses for soft tissue reconstruction.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, 3D Printing, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

breast reconstruction3D bioprintingregenerative medicinetissue engineeringbioprosthesisresorbable implantdissolvable implantsoft tissue reconstructiontissue scaffoldmastectomy reconstructiontissue regenerationmedical devicebio-inkhydrogellipofillingfat graftingnipple reconstruction

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Healshape Comps

Public and private peers based on sector, stage, and business model.

Healshape comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Healshape Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 28, 2022
GrantJul 16, 2020
AcceleratorJan 28, 2020

Key People

Founding team and executive leadership

Amelie THEPOT

COO, Co-founder

Founding Team

Caroline Durand

Co-Founder - Chief Development Officer

Founding Team

MORGAN DOS SANTOS

Co-Founder I Special Advisor To The CEO

Founding Team

Sophie Brac de la Perrière

CEO

Executive Team

Healshape Investors

Notable investors and investment history

Healshape investors
InvestorRounds
Les Premières Auvergne-Rhône-AlpesAccelerator
GO CapitalSeed
Angels SantéSeed
PulsalysAccelerator
WinEquitySeed
Crédit Agricole CréationSeed
BpifranceSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 5, 2024

    Grew 17% QoQ, from 18 to 21 employees.

  • Jun 28, 2022

    $6.3M round led by Demea Sustainable Investment and GO Capital.

Healshape Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Healshape Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Healshape's valuation, stock price, and market status.

Firmographic Details

HeadquartersLyon
Employee Range27
Year Founded2020
Last FundingJun 28, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.